Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.
from The Medical News http://ift.tt/1vBE95h
from The Medical News http://ift.tt/1vBE95h
No comments:
Post a Comment